Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
198 |
|
Actual shortage: | 8 (4%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 3 (2%) | |
Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 26 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-02-27 | 2024-03-19 | 220718 |
NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML | 5G 20MG | SOLUTION | Resolved | 2019-03-01 | 2019-03-19 | 77245 |
NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML | 5G 40MG | SOLUTION | Resolved | 2019-05-01 | 2019-05-22 | 82898 |
NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Resolved | 2018-05-23 | 2018-06-22 | 50095 |
NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Resolved | 2018-11-22 | 2019-02-27 | 67436 |
OLIMEL 4.4% E | 2.64G 0.74G 1.50G 6.41G 8G 154G 3.67G 0.81G 0.52G 2.24G 32G 2.21G 3.07G 2.21G 0.11G 2.64G 4.34G 2.83G 1.28G 2.21G 3.07G 3.07G 2.21G 3.48G 1.75G | EMULSION | Resolved | 2017-07-10 | 2017-08-16 | 15024 |
PLASMA-LYTE A INJECTION | 368MG 30MG 37MG 526MG 502MG | SOLUTION | Resolved | 2019-02-15 | 2019-03-19 | 76031 |
PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-09-01 | 122375 |
PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-08-18 | 122377 |
PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2018-03-19 | 2020-06-10 | 43360 |
PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2018-03-23 | 2020-06-10 | 43857 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 300MG 900MG | SOLUTION | Resolved | 2017-05-04 | 2017-09-26 | 9057 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2022-02-25 | 2022-03-26 | 155672 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2022-08-31 | 2022-11-02 | 168276 |
POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-01-12 | 2018-02-06 | 35770 |
POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-08-13 | 2018-08-29 | 58038 |
POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-12-14 | 2018-12-20 | 69676 |
POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2019-07-16 | 2019-11-29 | 89426 |
POTASSIUM CHLORIDE INJECTION | 14.9MG | LIQUID | Resolved | 2019-01-25 | 2019-02-05 | 73584 |
POTASSIUM CHLORIDE INJECTION | 14.9MG | LIQUID | Resolved | 2019-03-01 | 2019-03-07 | 77248 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
CLINOLEIC 20% | 4% 16% | EMULSION | Discontinued | 2017-04-04 | 2018-01-01 | 5289 |
NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91378 |
NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91382 |
NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91385 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |